Neha Vapiwala, MD
The Abramson Cancer Center of the University of Pennsylvania
Last Modified: September 27, 2005
Mar 21, 2011 - Higher plasma levels of the soluble tumor necrosis factor receptor 2 (sTNFR-2) appear to be associated with an increased risk of colorectal cancer (CRC) among women, with anti-inflammatory drugs reducing the risk of CRC among women with high baseline sTNFR-2 levels, according to a study published in the March issue of Gastroenterology.
Mar 21, 2011